Sign Up Today and Learn More About Bright Peak Therapeutics Stock
Invest in or calculate the value of your shares in Bright Peak Therapeutics or other pre-IPO companies through EquityZen's platform.
Bright Peak Therapeutics Stock (BRPT)
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.
About Bright Peak Therapeutics Stock
Founded
2017
Industries
Science and Engineering, Health Care, Biotechnology
Bright Peak Therapeutics Press Mentions
Stay in the know about the latest news on Bright Peak Therapeutics
Bright Peak Therapeutics to Participate in 43rd Annual J.P. Morgan Healthcare Conference
biospace • Jan 07, 2025
Bright Peak Therapeutics to Participate in 43rd Annual J.P. Morgan Healthcare Conference
globenewswire • Jan 06, 2025
Bright Peak Therapeutics Presents New Data at the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
globenewswire • Nov 08, 2024
Bright Peak Raises $90M Series C
sdbj • Jul 04, 2024
Bright Peak secures $90 million in Series C financing
thepharmaletter • Jul 04, 2024
Bright Peak Therapeutics Management
Leadership team at Bright Peak Therapeutics
Co-Founder, Senior Vice President & Head of Technology
Vijaya Pattabiraman
Co-Founder & Scientific Advisor
Jeffrey Bode
Join now and verify your accreditation status to gain access to:
- Bright Peak Therapeutics current valuation
- Bright Peak Therapeutics stock price
- Available deals in Bright Peak Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Bright Peak Therapeutics Stock
How to invest in Bright Peak Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Bright Peak Therapeutics through EquityZen funds. These investments are made available by existing Bright Peak Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Bright Peak Therapeutics stock?
Shareholders can sell their Bright Peak Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 340K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 44K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
